Victoria E. Wang

489 total citations
6 papers, 153 citations indexed

About

Victoria E. Wang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Victoria E. Wang has authored 6 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Victoria E. Wang's work include Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Victoria E. Wang is often cited by papers focused on Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Victoria E. Wang collaborates with scholars based in United States, Netherlands and France. Victoria E. Wang's co-authors include Anatoly Urisman, Siraj M. Ali, Vincent A. Miller, Andrew H. Ko, Jennifer R. Grandis, David M. Jablons, Rahul Aggarwal, Lee A. Albacker, Shannon Fogh and Frank McCormick and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Oncologist.

In The Last Decade

Victoria E. Wang

6 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victoria E. Wang United States	4	109	73	49	37	31	6	153
Renaud Maire Switzerland	5	136 1.2×	112 1.5×	38 0.8×	25 0.7×	56 1.8×	7	205
Martina Hinterleitner Germany	6	67 0.6×	36 0.5×	36 0.7×	14 0.4×	24 0.8×	17	110
Fabio Gelsomino Italy	7	67 0.6×	38 0.5×	17 0.3×	10 0.3×	25 0.8×	19	99
Marcin Zeman Poland	6	85 0.8×	35 0.5×	47 1.0×	13 0.4×	14 0.5×	25	185
Marina Sahade Brazil	5	56 0.5×	34 0.5×	18 0.4×	23 0.6×	23 0.7×	7	89
Alice Baggi Italy	6	66 0.6×	23 0.3×	20 0.4×	64 1.7×	15 0.5×	13	109
Vanesa Gutiérrez Spain	6	110 1.0×	52 0.7×	45 0.9×	61 1.6×	5 0.2×	13	134
Anne‐Laure Védié France	6	41 0.4×	44 0.6×	44 0.9×	15 0.4×	6 0.2×	11	153
Leah Ensell United Kingdom	6	107 1.0×	66 0.9×	13 0.3×	28 0.8×	43 1.4×	12	129
Keijiro Ueda Japan	9	104 1.0×	82 1.1×	20 0.4×	25 0.7×	31 1.0×	29	160

Countries citing papers authored by Victoria E. Wang

Since Specialization

Citations

This map shows the geographic impact of Victoria E. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria E. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria E. Wang more than expected).

Fields of papers citing papers by Victoria E. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria E. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria E. Wang. The network helps show where Victoria E. Wang may publish in the future.

Co-authorship network of co-authors of Victoria E. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria E. Wang. A scholar is included among the top collaborators of Victoria E. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria E. Wang. Victoria E. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wang, Victoria E., Jenny Y. Xue, Dennie T. Frederick, et al.. (2019). Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation. Clinical Cancer Research. 25(23). 7202–7217. 37 indexed citations

2.

Shah, Khyati N., Julia Rotow, Julia Rohrberg, et al.. (2019). Abstract 2902: Non-genetic TPX2/AURKA signaling facilitates tumor evolution in EGFR-TKI resistance in NSCLC. Cancer Research. 79(13_Supplement). 2902–2902. 2 indexed citations

3.

Wang, Victoria E., Anatoly Urisman, Lee A. Albacker, et al.. (2017). Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden. Journal for ImmunoTherapy of Cancer. 5(1). 75–75. 52 indexed citations

4.

Wang, Victoria E., Lauren Young, Siraj M. Ali, et al.. (2017). A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases. The Oncologist. 22(7). 768–773. 33 indexed citations

5.

Wang, Victoria E., Jennifer R. Grandis, & Andrew H. Ko. (2016). New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints. Clinical Cancer Research. 22(17). 4283–4290. 28 indexed citations

6.

Wang, Victoria E., Frank McCormick, & Jeffrey Settleman. (2014). Abstract 3698: Hyperactive AKT pathway and reactivation of the MAPK/ERK pathway in melanoma cells resistant to dual BRAF and MEK inhibition. Cancer Research. 74(19_Supplement). 3698–3698. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact